The new 2023 ESC guidelines for the management of cardiomyopathies: a guiding path for cardiologist decisions
{{output}}
In the ESC 2023 guidelines, cardiomyopathies are conservatively defined as 'myocardial disorders in which the heart muscle is structurally and functionally abnormal, in the absence of coronary artery disease, hypertension, valvular disease, and congenital hear... ...
